These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28927788)

  • 1. A structural investigation of FISLE-412, a peptidomimetic compound derived from saquinavir that targets lupus autoantibodies.
    He M; Cheng KF; VanPatten S; Bloom O; Diamond B; Al-Abed Y
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4725-4729. PubMed ID: 28927788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.
    Bloom O; Cheng KF; He M; Papatheodorou A; Volpe BT; Diamond B; Al-Abed Y
    Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10255-9. PubMed ID: 21646518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies.
    VanPatten S; Sun S; He M; Cheng KF; Altiti A; Papatheodorou A; Kowal C; Jeganathan V; Crawford JM; Bloom O; Volpe BT; Grant C; Meurice N; Coleman TR; Diamond B; Al-Abed Y
    J Med Chem; 2016 Oct; 59(19):8859-8867. PubMed ID: 27603688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies.
    Wang Y; Xiao S; Xia Y; Wang H
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):152-165. PubMed ID: 34542806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Hydroxy-tetrahydroquinolines from Quinolines Using Chloroborane: Synthesis of the Peptidomimetic FISLE-412.
    Altiti AS; Cheng KF; He M; Al-Abed Y
    Chemistry; 2017 Aug; 23(45):10738-10743. PubMed ID: 28639294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
    Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
    J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell-associated B7-H3 suppresses the production of autoantibodies and renal inflammation in a mouse model of systemic lupus erythematosus.
    Zheng X; Xiao ZX; Hu L; Fang X; Luo L; Chen L
    Cell Death Dis; 2019 May; 10(6):393. PubMed ID: 31113935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice.
    Lee TP; Huang JC; Liu CJ; Chen HJ; Chen YH; Tsai YT; Yang W; Sun KH
    Exp Biol Med (Maywood); 2014 Jun; 239(6):715-23. PubMed ID: 24719374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics.
    Gordon RE; Nemeth JF; Singh S; Lingham RB; Grewal IS
    Trends Biotechnol; 2021 Mar; 39(3):298-310. PubMed ID: 32807530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement.
    Mevorach D; Raz E; Steiner I
    Lupus; 1994 Apr; 3(2):117-21. PubMed ID: 7920611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.
    Hanly JG; Su L; Farewell V; Fritzler MJ
    J Immunol Methods; 2010 Jun; 358(1-2):75-80. PubMed ID: 20438730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA anti-dsDNA antibodies: A neglected serological parameter in systemic lupus erythematosus.
    Lee AYS
    Lupus; 2022 Feb; 31(2):137-142. PubMed ID: 35049409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
    Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
    J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus.
    Lewis MJ; McAndrew MB; Wheeler C; Workman N; Agashe P; Koopmann J; Uddin E; Morris DL; Zou L; Stark R; Anson J; Cope AP; Vyse TJ
    J Autoimmun; 2018 Jul; 91():1-12. PubMed ID: 29576246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus.
    Lindorfer MA; Schuman TA; Craig ML; Martin EN; Taylor RP
    J Immunol Methods; 2001 Feb; 248(1-2):125-38. PubMed ID: 11223074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update on Antibodies to Necleosome Components as Biomarkers of Sistemic Lupus Erythematosus and of Lupus Flares.
    Ghiggeri GM; D'Alessandro M; Bartolomeo D; Degl'Innocenti ML; Magnasco A; Lugani F; Prunotto M; Bruschi M
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.